Alaska Permanent Fund Corp Horizon Therapeutics Public LTD CO Transaction History

Alaska Permanent Fund Corp

  • $6.78 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$62.39 - $113.8 $6,363 - $11,607
-102 Reduced 10.14%
904 $103,000
Q3 2022

Oct 31, 2022
SELL
$58.92 - $84.67 $10,782 - $15,494
-183 Reduced 15.39%
1,006 $62,000
Q2 2022

Aug 09, 2022
BUY
$79.4 - $116.36 $94,406 - $138,352
1,189 New
1,189 $95,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email